Inventor · disambiguated record
Jurgen Mestan
Also filed as: MESTAN JUERGEN · MESTAN JURGEN
11 granted patents·5 pending applications·330 citations·filing 1995–2010
92Inventor score
Top patents by PatentIndex Score
16 records- 0195US6448277B2VEGF receptor tyrosine kinase inhibitorsNOVARTIS AG·Filed 2001·Granted Sep 10, 2002·64 cites·19 claims
- 0294US6878720B2VEGF receptor tyrosine kinase inhibitorsNOVARTIS AG·Filed 2002·Granted Apr 12, 2005·50 cites·16 claims
- 0392US5807891AAntiviral ethers of aspartate protease substrate isosteresCIBA GEIGY AG·Filed 1997·Granted Sep 15, 1998·54 cites·13 claims
- 0489US7002022B2N-Aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGFSCHERING AG·Filed 2004·Granted Feb 21, 2006·24 cites·8 claims
- 0586US7122547B1Anthranilic acid amides and the use thereof as medicamentsNOVARTIS AG·Filed 1999·Granted Oct 17, 2006·79 cites·14 claims
- 0685US5663200AAntiviral ethers of aspartate protease substrate isosteresCIBA GEIGY CORP·Filed 1995·Granted Sep 2, 1997·28 cites·11 claims
- 0782US7666874B2Pyrimidylaminobenzamide derivatives for hypereosinophilic syndromeNOVARTIS AG·Filed 2006·Granted Feb 23, 2010·6 cites·4 claims
- 0880US8673930B2Pyrimidylaminobenzamide derivatives for systemic mastocytosisALLAND LEILA·Filed 2010·Granted Mar 18, 2014·6 cites·5 claims
- 0980US8119649B2Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemiaDONATO NICHOLAS J·Filed 2009·Granted Feb 21, 2012·1 cites·6 claims
- 1079US5935976AAntiviral ethers of aspartate protease substrate isosteresNOVARTIS AG·Filed 1998·Granted Aug 10, 1999·18 cites·10 claims
- 1168US2007149539A1Use of c-src inhibitors alone or in combination with sti571 for the treatment of leukaemiaDONATO NICHOLAS J·Filed 2007·Application pending·0 cites
- 1264US8268837B2Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemiaDONATO NICHOLAS J·Filed 2005·Granted Sep 18, 2012·0 cites·1 claims
- 1359US2004248906A1Use of c-src inhibitors alone or in combination with st1571 for the treatment of leukaemiaFiled 2002·Application pending·0 cites
- 1457US2006074112A1N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitorsALTMANN KARL-HEINZ·Filed 2005·Application pending·0 cites
- 1557US2007027167A1Use of c-Src inhibitors alone or in combinaton with STI571 for the treatment of leukaemiaDONATO NICHOLAS J·Filed 2006·Application pending·0 cites
- 1649US2008176879A1Pyrimidylaminobenzamide Derivatives For Sytemic MastocytosisALLAND LEILA·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jurgen Mestan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →